Attention deficit and hyperactivity disorder: a therapeutic option
| Autor: | Abram Topczewski |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
medicine.medical_specialty
Pediatrics Imipramine medicine.drug_class Tricyclic antidepressant lcsh:Medicine Estimulantes do sistema nervoso central Antidepressive Agents Tricyclic Antidepressants/therapeutic use Anxiolytic Ansiolíticos/uso terapêutico Central nervous system stimulants medicine Attention deficit hyperactivity disorder Humans Psychiatry Child Retrospective Studies Antidepressivos/uso terapêutico Therapeutic regimen business.industry Artigo Original lcsh:R Chlordiazepoxide General Medicine Transtorno do déficit de atenção com hiperatividade medicine.disease Attention deficit disorder with hyperactivity Treatment Outcome Anti-Anxiety Agents Attention deficit Anxiolytics/therapeutic use Drug Therapy Combination Original Article business |
| Zdroj: | Einstein (São Paulo), Vol 12, Iss 3, Pp 310-313 Einstein einstein (São Paulo) v.12 n.3 2014 Einstein (São Paulo) Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE) instacron:IIEPAE |
| ISSN: | 2317-6385 |
| Popis: | Objective To evaluate the use of a therapeutic regimen to treat attention deficit hyperactivity disorder patients. Methods A total of 140 patients initially underwent physical, neurological and laboratory evaluation. Thereafter, treatment was initiated with a compounding product consisting of a tricyclic antidepressant and an anxiolytic. Results The response was positive in 71.43% of patients in controlling hyperactivity and improving dispersion and attention deficit. Conclusion The therapeutic regimen utilized proved to be an effective therapeutic alternative, especially for patients who do not adapt to psychostimulant drugs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|